Skip to main content

Resveratrol’s Low-Dose Anticancer Effect

The antioxidant found in red wine and some berries shows that small doses have more potent antitumor effects than large doses in a mouse model.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WIKIMEDIA, LOURDES CARDENALSmall amounts of resveratrol, the chemical in red wine and some berries that is purported to have cancer-fighting properties, may be more effective at preventing tumor growth than larger doses, according to researchers studying cancer-prone mice. A team of scientists from the U.K. and the U.S. published its results in Science Translational Medicine on Wednesday (July 29).

“For the first time, we’re seeing that less resveratrol is more,” team leader Karen Brown of the University of Leicester said in a statement. “This study shows that low amounts may be better at preventing tumors than taking a high dose.”

Brown and her team studied mice that had been engineered to spontaneously develop bowel cancer. After feeding the animals a high fat diet with varying amounts of resveratrol, the researchers found that a dose that was equivalent to a human adult consuming a large glass of red wine was more effective at shrinking tumors than a dose 200 times higher. Tumors in mice administered low doses of resveratrol shrunk by 50 percent, while the high-resveratrol dose mice showed only a 25 percent reduction in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo